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Abstract
Background: Asbestos has been shown to cause chromosomal damage and DNA aberrations.
Exposure to asbestos causes many lung diseases e.g. asbestosis, malignant mesothelioma, and lung
cancer, but the disease-related processes are still largely unknown. We exposed the human cell
lines A549, Beas-2B and Met5A to crocidolite asbestos and determined time-dependent gene
expression profiles by using Affymetrix arrays. The hybridization data was analyzed by using an
algorithm specifically designed for clustering of short time series expression data. A canonical
correlation analysis was applied to identify correlations between the cell lines, and a Gene
Ontology analysis method for the identification of enriched, differentially expressed biological
processes.
Results: We recognized a large number of previously known as well as new potential asbestos-
associated genes and biological processes, and identified chromosomal regions enriched with genes
potentially contributing to common responses to asbestos in these cell lines. These include genes
such as the thioredoxin domain containing gene (TXNDC) and the potential tumor suppressor,
BCL2/adenovirus E1B 19kD-interacting protein gene (BNIP3L), GO-terms such as "positive
regulation of I-kappaB kinase/NF-kappaB cascade" and "positive regulation of transcription, DNA-
dependent", and chromosomal regions such as 2p22, 9p13, and 14q21. We present the complete
data sets as Additional files.
Conclusion: This study identifies several interesting targets for further investigation in relation to
asbestos-associated diseases.
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Background
Asbestos causes DNA double strand breaks [1], chromo-
somal aberrations, and abnormal chromosome segrega-
tion [2]. Asbestos fibre-induced genotoxicity has been
proposed to be caused by both a direct interaction with
the genetic material and also indirect effects via produc-
tion of reactive oxygen species (ROS) [3]. The respiratory
diseases linked to asbestos exposure include fibrotic lung
disease, mesothelioma, and lung cancer. The pathogene-
sis and histopathology of asbestosis resemble that of idio-
pathic pulmonary fibrosis. Some specific genes
contributing to the development of asbestosis and asbes-
tos-related cancer have been described, as reviewed in [4].
However, the exact molecular mechanisms behind asbes-
tos-associated carcinogenesis and fibrosis/asbestosis are
thought to be very complex and involve several parallel
pathways [4,5] that remain to be clarified.
Asbestos exposure has been reported to alter the expres-
sion of several genes involved in integrin-mediated signal-
ing pathways, MAPK pathways, and NFKB/IKB pathways
[6]. A recent study in a model for asbestos-induced onco-
genesis demonstrated that the tumor necrosis factor, TNF-
α, triggered by macrophages, induced activation of the
NFKB cascade and thereby blocked apoptosis [7].
Studies from this laboratory as well as from others, have
examined the gene copy number and expression changes
in lung cancer patients with asbestos exposure and in mes-
othelioma. These have revealed a very complex pattern of
chromosomal aberrations and altered gene expression,
i.e. evidence for specific asbestos-associated aberrations
and altered expression profile in these cancer genomes [8-
10].
Given the evidence of association between fibrosis and
cancer, it is clearly important to identify the specific genes
involved in the inflammatory, fibrotic, and carcinogenetic
processes in the lung following asbestos exposure, as
reviewed in [4]. Chromosomal aberrations, together with
more accurate information of gene expression alterations
caused by asbestos, could provide valuable clues in the
search for novel therapeutic targets.
We used three human lung cell lines to map the gene
expression following crocidolite exposure. In addition to
epithelial cells, mesothelial cells with features of both
mesenchymal and epithelial cells [11], were used in the
identification of asbestos-affected genetic pathways. Croc-
idolite was selected as it is probably the most pathogenic
amphibole fibre, possibly due to its high iron content [4].
We report for the first time specific time-dependent
genome-wide expression profiles in asbestos exposed
human lung adenocarcinoma cells (A549), non-tumori-
genic SV40-immortalized bronchial (Beas-2B), and pleu-
ral mesothelial cells (MeT5A).
Results
The overall study design is illustrated in Fig. 1.
Gene Ontology Analysis Results
An analysis to detect enriched Gene Ontology (GO) terms
was carried out separately for all cell lines at several time
points. We searched for branches with at least three
enriched GO terms (p < 0.01) and the most detailed term
containing less than 100 genes was listed (Additional file
1, GOanalysis). A total of 351 unique branches of the GO
tree were enriched in at least one cell line at any one time
point.
The GO terms at the 1 h and 48 h time points were com-
pared between the cell lines to identify commonly
enriched biological processes. Again, we restricted our
focus to those branches of the GO tree that contained at
least three enriched GO terms. No common processes
were observed after 1 h exposure, whereas 10 common
GO terms were identified after 48 h. We consider these
biological processes to be potentially asbestos-associated
since they were enriched in all cell lines. The number of
genes belonging to the most detailed process of the
branch ranged from 1 to 85 (Table 1). The complete
results from all cell lines and all time points are appended
in Additional file 1: GOanalysis.
Cluster Analysis Results
The differential expression according to asbestos-exposure
at different time points was studied by cluster analysis and
revealed 12 significant clusters in A549, 16 in Beas-2B,
and 3 in MeT5A (Fig 2 and Additional files 2 and 3:
A549clusters and Beas2Bclusters), with the total number
of genes included in the cluster analysis results being
18,535. Fig. 3 illustrates the statistical significance of the
attained clusters in each cell line. The clusters can be
ordered with respect to their significance, based on the
expected and realized number of probe sets assigned to
the clusters. The clusters are not numbered in the exact
order of significance due to the limits of numerical preci-
sion in the computation of p-values. The number of
probes for each cluster ranged between 174 and 1,653,
266 and 2,073, and 1,085 and 2,403 (Additional file 4:
Cluster_analysis), and the number of significant GO
terms for each cluster ranged from 4 to 56, 1 to 45, and 10
to 52, whereas the number of enriched chromosomal
regions ranged from 5 to 23, 2 to 15, and 8 to 11 (data not
shown, available upon request) in the A549, Beas-2B and
MeT5A cell lines, respectively. Further interpretation and
discussion of the results focuses on the three most signifi-
cant clusters in each cell line. These clusters were chosen
according to the expected and realized number of probeBMC Genomics 2007, 8:62 http://www.biomedcentral.com/1471-2164/8/62
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sets assigned to them; in order of significance the clusters
were 5, 9, and 1 in A549; 8, 1, and 5 in Beas-2B; and 1–3
in MeT5A (Fig. 2).
We compared the enriched biological processes in the
clusters and in the GO analysis and found 29 common
processes (data obtained upon request), of which 9 were
significant in at least two clusters and at least two time
points of the GO analysis (Table 2). The GO terms "nega-
tive regulation of survival gene product activity" and "pos-
itive regulation of transcription, DNA-dependent"
matched with those obtained in the GO analysis of the 48
h time point and "cytoplasmic sequestering of NF-kap-
paB" was closely related to a third GO term in the 48 h
analysis (Table 1).
The most significant cluster of A549 (cluster 5) contained
enrichment of genes located in nine of the 18 previously
identified chromosomal regions with copy number
changes in asbestos-associated lung cancer [8], i.e., 11q13,
19p13, 9q34, 16p13, 1p36, 17p13, 5q35, 3p21, and
22q13 (p < 0.01). Also cluster 2 of A549 contained enrich-
ment of genes in 5 regions corresponding to the asbestos-
associated regions in lung cancer. In total, clusters 5 and 2
contained enrichment of genes in 23 and 9 regions,
respectively. The less significant clusters 3, 7, and 13 in
Beas-2B contained enrichment of genes in 3 to 5 regions
and cluster 2 in MeT5A contained enrichment of genes in
5 regions corresponding to the asbestos-associated
regions. Overall, these clusters 3, 7 and 13 in Beas-2B and
2 in MeT5A contained enrichment of genes in 8, 14, 7,
and 11 regions (p < 0.01), respectively (data obtained
upon request).
Based on the literature, we examined 559 previously iden-
tified asbestos-associated genes to check their representa-
tion in the clusters. The Affymetrix probe sets
corresponding to the listed genes were obtained with the
data mining tool BioMart at Ensembl [12], based on the
HGNC symbols. A total of 1,362 probe sets in the array
represented the 559 asbestos-associated genes. Table 3
lists 55 of the probe sets corresponding to the previously
known potential asbestos-, ROS- or mesothelioma-associ-
ated genes that were included in significant clusters in all
cell lines. It is noteworthy that five collagen genes were
recognized in significant clusters in all cell lines. Changes
Overall study design Figure 1
Overall study design.
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Table 1: GO analysis results. Differentially expressed biological processes common in all cell lines after 48 h of exposure.
GO term* P-value/expression Genes contributing to the differential expression Total no. of genes in 
the GO term
Negative regulation of helicase 
activity
< 0.01/down TP53 2
Regulation of mitochondrial 
membrane permeability
< 0.01/down TP53 8
Positive regulation of transcription, 
DNA-dependent
< 0.005/down ARID1A, THRAP3, GLIS1, FOXD3, ARHGEF11, ATF6, ESRRG, 
NCOA1, FHL2, CTNNB1, SCAP, SMARCC1, ZBTB38, TP73L, 
PPARGC1A, NARG1, MAML3, IL31RA, CDK7, RNF14, 
PPARGC1B, NSD1, MAML1, SQSTM1, NOTCH4, HMGA1, 
TBN /// LOC441149, TBN, TRERF1, FOXO3A, ASF1A, 
PLAGL1, ARID1B, CREB5, SMARCD3, GATA4, GLIS3, RXRA, 
NCOA4, EHF, HTATIP, RBM14, RBM14 /// MGC15912, 
HBXAP, CRSP6, MAML2, ATF7IP, SURB7, SP1, SMARCC2, 
GRIP1, TBX5, RAN /// LOC391717, NARG1L, RB1, TXNDC, 
MED6, TP53BP1, ELL3, PIAS1, MKL2, TGFB1I1, CTCF, 
MAP2K3, PPARB, BRCA1, THRAP, PIAS2, SMAD2, ILF3, 
MECT1, CCNE1, MLL4, DYRK1B, NCOA3, NRIP1, RUNX1, 
SEC14L2, ATF4, PHF5A, G22P1, CRSP2, MED12
848
Negative regulation of JNK activity < 0.01/down HIPK3 5
Prenylated protein catabolism < 0.01/down PCYOX1 4
Negative regulation of survival 
gene product activity
< 0.01/down BNIP3L, HRK, BCL2L1, BAX 19
Ras protein signal transduction < 0.01/down PARK7, MFN2, CNKSR1, LCK, NOTCH2, IQGAP3, SOS1, 
LZTFL1, RASSF1, MRAS, PLD1, G3BP2, FGF2, IQGAP2, 
KIAA1961, RAPGEF6, G3BP, RREB1, RGL2, PLCE1, SHOC2, 
RASGRP2, IGF1, RASGRP1, TPM1, IQGAP1, LAT, GAS8, GRAP, 
KSR, NF1, GRB2, RASGRP4, RRAS, NU62, NUP62 /// IL4I1, 
CRKL, GRAP2
477
Cytoplasmic sequestering of NF-
kappaB
< 0.005/down FAF1, IL10, G3BP2, NFKBIA, BCL3 22
Regulation of MAPK activity < 0.005/down MAP3K6, SHC1, RGS4, LAX1, KIAA1804, TRIB2, SPRED2, 
DUSP2, MAP3K2, ZAK, PROK2, PIK3CB, ADRA2, EGF, FGF2, 
PRKAA1, PPP2, DUSP22, DAXX, MAPK3K5, DBNL, PP2CB, 
TRIB1, RGS3, PLCE1, DUSP8, HPK3, MAP3K11, PP2R1B, 
DUSP6, MBIP, MAP4K5, MAP3K9, SPRED1, HSPC121, GPS2, 
ADORA2B, GPS1, EDG5, PKN1, MAP4K1, MAP3K10, C5R1, 
PPP2R1, TRIB3, BIRC7, DUSP9
244
Sensory perception of smell < 0.005/up TAS1R1, TAS1R2, OR10K1, OR10, OR2C3, OR1C1, OR2W3, 
OR2L13, OR2M4, ADCY3, GRM7, SLIT2, YGT2A1, TAS2R1, 
OR2B2, ORB2B6, OR2W1, OR2B3, OR5U1, OR5V1, 
OR12D3, OR5V1 /// OR12D3, OR12D2, OR11A1, OR10C1, 
OR2H1, OR2H2, CYB5R4, TAS2R16, GRM8, TAS2R3, 
TAS2R4, TAS2R5, TAS2R38, OR6W1, TAS2R39, TAS2R40, 
TAS2R41, OR6B1, OR2S2, OR1J2, OR1J4, OR1Q1, OR51E1, 
OR51E2, OR52A1, OR51B4, OR51B2, OR51M1, OR51I1, 
OR51I2, OR52D1, OR6A2, OR10A4, OR5P2, OR5P3, PR5E1, 
OR10A3, OR5I1, OMP, OR8G1 /// LOC442754, OR8D1, 
OR8B2, OR8B8, TAS2R45, TAS2R7, TAS2R8, TAS2R9, 
TAS2R1, TAS2R13, TAS2R14, TAS2R50, OR4N4, OR1F1, 
OR1F2, OR2C1, OR1D2, OR1G1, OR1A2, OR1A1, OR3A2, 
OR3A1, OR1E1 /// OR1E2, OR4D1, OR4D2, OR7D2, 
OR7E19, OR7C1, OR7A5, OR7A10, OR7A17, OR7C2, OR1I1, 
OR10H2, C5R1
2589
*see Additional file 1: GOanalysis for all significant GO terms at each time point.BMC Genomics 2007, 8:62 http://www.biomedcentral.com/1471-2164/8/62
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Profiles of the most significant clusters in A549 (A-C), Beas-2B (D-F) and MeT5A (G-I) cells Figure 2
Profiles of the most significant clusters in A549 (A-C), Beas-2B (D-F) and MeT5A (G-I) cells. The X-axis shows the time points 
from 0 h-48 h (or in the case of A549, 7 days) and the Y-axis the expression ratio profile that is representative of all probe sets 
in the cluster. Due to the correlation-based distance measure used in the clustering method [48], the scale of the Y-axis is not 
relevant.
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in the expression of procollagen is known to accompany
the altered expression of TGF-β  and  FN1  following
amosite asbestos exposure [13].
Canonical Correlation Analysis Results
Canonical correlation analysis (CCA) was used to identify
genes that contribute to the statistical dependencies
between the A549 and Beas-2B cell lines. The MeT5A cell
line was excluded due to the scarce time points. Measure-
ments of differential gene expression between exposed
and non-exposed cells were used for both cell lines in the
analysis. Genes whose activation patterns show depend-
encies between two asbestos-exposed cell lines are more
likely to be related to the asbestos exposure.
To achieve robust results, interpretation of the results was
focused on gene groups rather than individual genes. We
hypothesized that asbestos effects are spatially localized
in chromosomes, and tested whether certain chromo-
somal regions were enriched in the gene list obtained by
CCA. These regions could be potentially asbestos-affected
(asbestos hotspots), and common to the cell lines.
Table 4 lists the most significant 21 regions (p-value <
0.03; q-value < 0.38). The number of genes contributing
to the significance ranged from 1 to 71 genes (Additional
file 5: CCA).
In the cluster analysis, the most significant cluster in Beas-
2B (cluster 8; enrichment of genes in 10 regions) con-
tained 3 regions corresponding to the regions identified in
CCA (Table 4) and cluster 1 in MeT5A (enrichment of
genes in 8 regions) contained 4 regions matching the CCA
results, whereas none of the clusters in A549 had more
than one region corresponding to the CCA results. Both
the cluster analysis and CCA aim at revealing asbestos-
related response, but they focus on different aspects of the
data. In the three MeT5A clusters (enrichment of genes in
29 regions in total), we observed enrichment of genes in
7 regions corresponding to the CCA results, emphasizing
that the changes do seem to reflect asbestos damage also
in mesothelial cells.
Biological processes, such as "positive regulation of tran-
scription, DNA-dependent" and "negative regulation of
survival gene product activity", seen in the cluster and GO
analyses (Table 2), were also associated with the genes in
the regions of the CCA. Other processes that were found
both in the CCA and the GO analysis were "calcium ion
homeostasis", "frizzled signaling pathway", and "frizzled-
2 signaling pathway", all known to contain asbestos asso-
ciated genes [14]. These analyses are not, however,
directly comparable, since they concentrate on different
aspects of the data.
The CCA results were also correlated with the recently
described germline 8-oxoguanine-rich regions in the
human genome and the most significant 10 regions were
found to be significantly associated with the 8oxoG
regions (p = 0.024). These 8oxoG regions correlate with
chromosomal regions that are frequently involved in
recombination in the human genome. The regions
affected by recombination are claimed to be more prone
to damage through strand breaks [15].
Discussion
We exposed transformed lung epithelial and mesothelial
cells to asbestos and hybridized the samples from 3 to 6
time points to Affymetrix oligonucleotide arrays. The
expression results were analyzed using three different
methods to profile the expression pattern evoked by
asbestos exposure (Fig. 1). The aim of this study was to
profile gene expression at a genome-wide level to enable
also other researchers to choose possible candidates for
The significance of each cluster in A549 (A), Beas-2B (B), and MeT5A (C) Figure 3
The significance of each cluster in A549 (A), Beas-2B (B), and MeT5A (C). The X-axis shows the number of expected probe 
sets and the Y-axis the number of assigned probe sets in each cluster. The clusters above the line are considered statistically 
significant based on permutation tests.
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Table 2: Cluster analysis versus GO analysis. Common up- and downregulated biological processes (GO) in the cluster analysis and the GO analysis. Processes significant in more than one 
time point of any cell line in the GO analysis and occurring in more than one cluster of any cell line.
GO biological process Cluster analysis GO analysis
A549 cluster number 
(uncorrected p-value)
Beas-2B cluster number (uncorrected p-
value)
MeT5A cluster number 
(uncorrected p-value)
Antigen processing, 
endogenous antigen via MHC 
class I
5 (9.52 × 10-10) 12 (1.31 × 10-3) A549 1 h up A549 24 h down
Apoptotic program 9 (2.58 × 10-3) 6 (3.00 × 10-3)2  ( 2 . 5 5  ×  1 0 -4) Beas-2B 24 h down A549 48 h down
Cytoskeletal anchoring 9 (2.04 × 10-3) 6 (2.44 × 10-3), 16 (1.38 × 10-3)2  ( 2 . 8 5  ×  1 0 -3) A549 24 h down MeT5A 48 h down
Nucleosome assembly 1 (5.68 × 10-4) 3 (2.52 × 10-3), 5 (4.02 × 10-3), 13 (1.13 × 10-3) Beas-2B 1 h down MeT5A 1 h up
Regulation of DNA replication 5 (9.56 × 10-3) 11 (3.02 × 10-3) A549 1 h up A549 6 h up Beas-2B 24 h down Beas-2B 48 h 
down
Regulation of translational 
initiation
1 (7.00 × 10-5)2  ( 5 . 7 3  ×  1 0 -3) A549 48 h down Beas-2B 6 h down Beas-2B 48 h down 
MeT5A 1 h up
Positive regulation of 
transcription, DNA-dependent
8 (1.59 × 10-3)2  ( 3 . 7 3  ×  1 0 -3) A549 48h down Beas-2B 6h down MeT5A 1h up MeT5A 
48h down
Positive regulation of I-kappaB 
kinase/NF-kappaB cascade
1 (5.98 × 10-3), 4 (1.03 × 10-4) 1 (2.36 × 10-3), 16 (1.17 × 10-4)2  ( 2 . 0 7  ×  1 0 -3) A549 6h up A549 24h down A549 48h down Beas-2B 6h 
down Beas-2B 24h down Beas-2B 48h down MeT5A 1h up
Negative regulation of survival 
gene product activity
8 (9.92 × 10-3)2  ( 4 . 0 6  ×  1 0 -4) A549 6h up A549 24h down A549 48h down Beas-2B 1h 
down Beas-2B 24h down Beas-2B 48h down MeT5A 1h up 
MeT5A 48h downBMC Genomics 2007, 8:62 http://www.biomedcentral.com/1471-2164/8/62
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Table 3: Asbestos-related genes. Previously identified potential asbestos-associated genes represented in significant clusters of all cell 
lines. (Affymetrix IDs are available upon request)
Asbestos-associated gene A549 cluster Beas-2B cluster MeT5A cluster Chr. loc
Mesothelioma-associated genes*
BIRC5 5 13 2 17q25
BTG2 57 3 1 q 3 2
CALU 98 3 7 q 3 2
CALU 98 3 7 q 3 2
COL1A1 5 10 2 17q21.33
COL4A1 5 8 2 13q34
COL5A1 5 14 2 9q34
COL6A2 5 3 2 21q22
FN1 96 3 2 q 3 4
HMGB1 9 3 2 13q12
HNRPH1 57 2 5 q 3 5
IGFBP4 4 10 3 17q21.2
KIBRA 56 3 5 q 3 4
LU 2 3 2 19q13
LU 2 10 3 19q13
NF2 5 7 2 22q12
PDLIM7 27 2 5 q 3 5
PDLIM7 57 2 5 q 3 5
PEG10 98 3 7 q 2 1
POM121 4 13 2 7q11
PTPRF 5 13 2 1p34
PXN 5 13 2 12q24
TPD52L1 5 6 1 6q22.31
TP53 5 7 2 17p13
TXN 11 1 1 9q31
VEGF 98 3 6 p 1 2
VEGF 98 3 6 p 1 2
VIL2 8 16 2 6q25.3
Human homologs of asbestos associated murine genes†
BIRC4 67 1 X q 2 5
BIRC4 7 13 1 Xq25
BMP2 5 14 1 20p12
CD44 9 14 2 11p13
CSNK2A1 9 13 2 20p13
CTSB 1 14 1 8p22
FAS 1 8 1 10q24
FAS 1 8 1 10q24
IQGAP1 9 6 3 15q26
MAP4K4 1 8 3 2q11.2
PLEC1 96 2 8 q 2 4
PTPN14 96 3 1 q 3 2
PTPRF 5 13 2 1p34
RHOA 96 2 3 p 2 1
TP53 5 7 2 17p13
TRAM1 58 2 8 q 1 3
VAV2 5 13 2 9q34
Other asbestos-associated genes‡
ADD3 5 8 3 10q24
CASP8 9 6 2 2q33.1
CDK10 5 13 2 16q24
COL12A1 9 8 2 6q13-14.1
FOSL2 23 3 2 p 2 3
IKBKB 9 16 2 8p11
KRAS 7 13 1 12p12
L1CAM 2 11 2 Xq28
MAPK1 3 5 3 22q11
MAPK1 9 6 2 22q11
MAPK1 9 6 2 22q11
NFKB2 5 13 3 10q24
PCDHGA6§ 12 10 3 5q31
PRKCD 56 3 3 p 2 1
* [17, 36–39]
†[6, 20]
‡ [4, 18, 19, 55, 56]
§ The probe also corresponds to PCDHGC3 /// PCDHGB4 /// PCDHGA8 /// PCDHGA12 /// PCDHGC5 /// PCDHGC4 /// PCDHGB7 /// PCDHGB6 /// 
PCDHGB5 /// PCDHGB3 /// PCDHGB2 /// PCDHGB1 /// PCDHGA11 /// PCDHGA10 /// PCDHGA9 /// PCDHGA7 /// PCDHGA6 /// PCDHGA5 /// PCDHGA4 /
// PCDHGA3 /// PCDHGA2 /// PCDHGA1BMC Genomics 2007, 8:62 http://www.biomedcentral.com/1471-2164/8/62
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further investigation. Therefore we do not intend to dis-
cuss all the new potentially asbestos-related genes, but
rather to select some examples. We are well aware that sin-
gle genes are of little interest in profiling experiments
when thousands of genes are evaluated. The genes we dis-
cuss here are some of those highlighted in three very
diverse analyses. For complete results, see Additional files
1, 2, 3, 4, 5: GOanalysis, Cluster_analysis, CCA,
A549clusters and Beas2Bclusters.
Many of the measured expression changes are probably
due to the triggering of various universal cellular
responses to foreign toxic substances, e.g., apoptosis or
cell death. We anticipated that the use of three different
cell lines would help us to pinpoint the specific asbestos-
related effects. I.e. by comparing and identifying changes
common to all cell lines, we expected to be able to neglect
the expression changes associated with the malignancy or
cell type and to concentrate on specific asbestos-related
changes common to all cell types. Indeed, the number of
GO terms shared by the cell lines increased with time,
implying that response to the exposure occurs through the
same pathways. Furthermore, the number of downregu-
lated biological processes in each cell line increased with
time, while the number of upregulated processes
decreased (Fig. 1, bottom charts). This could be a conse-
quence of apoptosis or cell death related functions. How-
ever, the failure of apoptotic functions to trigger cell death
has been proposed to precede carcinogenic changes in a
cell [16,17], making also the pathways and genes involved
in the apoptotic processes worth investigating.
The asbestos associated genes NFKB2 and IKBKB [18,19]
were present in the significant clusters of all cell lines
(Table 3) and the GO term, "positive regulation of I-kap-
paB kinase/NF-kappaB cascade", associated with these
genes was common for all the cell lines in both the cluster
analysis and the GO analysis (Table 2). In addition, the
genes within the GO term "cytoplasmic sequestering of
NF-kappa B" were downregulated after 48h of asbestos
exposure in all cell lines (Table 1). NFKB is known to be
upregulated by asbestos and indeed, both the pathways
and the probe sets corresponding to this gene exhibited
upregulation at the initial time points, but downregula-
tion at the later time points. This might be due to the fact
that cells treated with asbestos often undergo apoptosis or
cell death, whereas NFKB activation is involved in inhibi-
tion of apoptosis and cell survival [7].
Thioredoxin (TXN) and thioredoxin reductase (TXNRD1)
downregulate apoptotic processes. These genes have been
found to be upregulated in malignant pleural mesotheli-
oma [20,21] and TXN is also known to be involved in the
DNA-binding activity of NFKB [22,23]. TXNDC is located
Table 4: Chromosome bands from the CCA results. Potential asbestos hotspots, some of which contain known asbestos-related genes. 
Expected false discovery rate of < 38%.
Region P-value/q-value No. of genes in the region with the most significant contribution 
to the common correlation*
Examples of genes
2p22 0.00260/0.3367 10 MAP4K3†, CEBPZ§,QPCT§
9p13 0.00700/0.3367 71 FANCG†, IGFBPL1†, CCL19†MELK†
14q21 0.00720/0.3367 22 FANCM†, CDKL1†
5p13 0.00880/0.3367 5
9q21 0.00970/0.3367 29 PCSK5†
5q13 0.01010/0.3367 9 F2RL1
8q22 0.01160/0.3367 59 CTHRC1†, TP53INP1†, KLF10†
2q36 0.01260/0.3367 29 MRPL44†
6q13 0.01300/0.3367 9
2q31 0.01370/0.3367 28 KIAA1715, AGPS, ITGA4†, ITGA6†
3q29 0.01410/0.3367 54 DLG1
3p25 0.01480/0.3367 67 COLQ†, CAMK1†, RAF1†, TMEM43,LOC51244
15q12 0.0176/0.3471 2
4q11 0.0178/0.3471 6
8p21 0.0196/0.35672 70 BNIP3L, GSR§
12q12 0.0225/0.3705 7
14q22 0.0258/0.3705 29 TXNDC
2q34 0.0266/0.3705 1
15q13 0.0272/0.3705 9
5q15 0.0279/0.3705 2 KIAA0372§
3q23 0.0285/0.3705 4
* see Additional file 5: CCA for complete lists of the genes
† Known or related to a known asbestos-associated gene. ITGA4 also differentially expressed in asbestos-exposed lung cancer patients as compared 
to non-exposed lung cancer patients [10].
§ The gene also shows differential copy number in CGH array data of asbestos-exposed lung cancer patients, (data not shown, available at request)BMC Genomics 2007, 8:62 http://www.biomedcentral.com/1471-2164/8/62
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in 14q22, found in the CCA results. This thioredoxin-
related gene was also represented in a highly significant
cluster in all three cell lines. It is also one of the genes con-
tributing to differential expression of the GO term "posi-
tive regulation of transcription, DNA-dependent", which
was downregulated in all cell lines after 48h of asbestos
exposure (Table 1). This suggests that the activation of
thioredoxin and thioredoxin-related products, and subse-
quently NFKB, is evoked by other asbestos-activated prod-
ucts, e.g., TNF-α, derived from cell types other than the
epithelial cells.
BNIP3L is a potential tumor suppressor gene, associated
with hypoxia-induced epithelial injury [24]. Similar to
TXNDC, BNIP3L was represented in all analyses, i.e., in
the region 8p21 respresented in the CCA results, in the sig-
nificantly downregulated GO term "negative regulation of
survival gene product activity" (Tables 1 and 4), and it was
present in the highly significant clusters 1, 8, and 2 (A549,
Beas-2B, and MeT5A, respectively). TXNDC and BNIP3L
were the only genes represented with such high signifi-
cance in all analysis results and they can be readily envis-
aged as being associated with asbestos-related cellular
damage based on their functions and their relationships
with previously known asbestos-associated genes.
Asbestos-associated protein kinase c, delta (PKC-δ)and p-
adducin (ADD) [4,25] were represented in significant
clusters in all cell lines and ADD3 was represented in the
most significant cluster of all cell lines (Fig 2A, D and 2G).
ADD1 has also been found to be upregulated in asbestos-
exposed lung cancer patients [10]. Furthermore, PKC-δ
maps to a chromosomal area closely adjacent to 3p21, a
region that has recently been found to be more frequently
affected by loss of heterozygosity in asbestos-exposed
than in non-exposed lung cancer patients [8,26]. Crocido-
lite asbestos is believed to modulate the intracellular cal-
cium levels through activation of PKC, pointing to a
possible involvement of calcium related pathways and
genes [4]. We found both calcium-related genes and GO
terms in the results of all analyses.CAMK2D was repre-
sented in high-ranking clusters of all cell lines and the
potential asbestos hotspot regions identified by CCA har-
bored CAMK1. In addition, many other genes belonging
to calcium-related biological processes were represented
in the CCA data (Additional file 5: CCA). The GO analysis
revealed that the biological process "calcium ion trans-
port" had been affected in both Beas-2B and MeT5A cells
(Additional file 1: GOanalysis).
The only upregulated biological process common to all
three cell lines at the 48h time point in the GO analysis
was "sensory perception of smell", which has not previ-
ously been proposed to be asbestos-associated. The
majority of the genes involved in this process are G pro-
tein coupled olfactory receptors and taste receptors. G
proteins have been suggested to be involved in the respi-
ratory burst (release of ROS) caused by asbestos [27]. Fur-
thermore, many G protein-associated biological
processes, e.g., "G-protein signaling, coupled to IP3 sec-
ond messenger" and "G-protein coupled receptor protein
signaling pathway", were represented in our results (see
Additional files 1 and 5: GOanalysis and CCA). This could
indicate that the expression of G proteins is specifically
altered by asbestos, possibly causing the release of ROS,
which is known to contribute to carcinogenesis and pro-
gression to malignancy [28].
The most significant region according to the CCA was
2p22 (Table 4). It precedes a region (2p21-p16.3) that we
have previously shown to be differentially altered in lung
carcinomas of asbestos-exposed patients than in non-
exposed patients' carcinomas [8]. A region homologous to
the human 2p25-p21 has been reported to be amplified in
radon-induced rat lung tumors [29], which could point to
preferential damage that, for example, ROS production
caused in this region of the genome. Additionally, a c-fos-
like gene (FOSL2), which maps close to 2p21-p16.3, was
present in significant clusters of all cell lines (Table 3). The
early response genes c-fos and c-jun are closely linked to
asbestos exposure [30]. Our results also revealed that the
GO term "negative regulation of JNK activity", which reg-
ulates JUN kinase activity, was downregulated at the 48h
time point in all cell lines (Table 1). Based on these
results, the short arm of chromosome 2 could be an
important potential target for DNA damage by asbestos,
either directly or indirectly through ROS or other by-prod-
ucts. It is noteworthy that the probe sets located in 2p
were substantially enriched in the highly significant clus-
ters 9 of A549 (p = 0.00032) and 5 of Beas-2B (p =
0.000114) (data not shown).
Some of the crucial chromosomal aberrations in mesothe-
lioma occur in 3, 4q, 5p, 6q, 8q22-q23, 9p, 14q12-q24
and 15q [9,31-35]. These regions correspond to the CCA
results, strengthening the hypothesis that some chromo-
somal regions could be more prone to DNA damage
caused by asbestos. Additionally, CCA revealed two inter-
esting integrin genes in 2q31, ITGA4 and ITGA6. ITGA4
was significantly underexpressed in asbestos-exposed lung
cancer patients [10] and ITGA6 has been associated with
asbestos [6,36]. The long arm of chromosome 2 contains
two fragile sites, FRA2G and FRA2H closely preceding and
adjacent, respectively, to the region in the CCA results,
suggesting that damage in these areas could cause specific
changes in the expression of genes localized between the
fragile sites. We have previously found fragile sites to be
associated with asbestos-related copy number aberrations
in lung cancer patients [8]. Furthermore, the ITGA genes
are involved in calcium ion binding functions.BMC Genomics 2007, 8:62 http://www.biomedcentral.com/1471-2164/8/62
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The significant clusters of the differentially expressed
genes in the A549 cell line contained more genes located
in regions corresponding to regions with differential copy
number changes in asbestos-related lung cancer than was
the case with the Beas-2B and MeT5A cell lines. This could
possibly be attributable to the fact that A549 is a malig-
nancy-derived cell line from a lung adenocarcinoma,
whereas Beas-2B and MeT5A are SV40-transformed non-
malignant cells that may exhibit the early effects of asbes-
tos more clearly. This hypothesis is strengthened by the
finding of enrichment of differentially expressed genes in
regions corresponding to the CCA results in the clusters of
the MeT5A cells, although this cell line was not included
in the CCA.
Conclusion
This study describes the asbestos-related gene expression
profiles in lung epithelial and mesothelial cells at differ-
ent time points. Clearly, in vitro experiments can never
precisely reflect the conditions and mechanisms in vivo;
for example, interactions between inflammatory cells and
with the extra-cellular matrix are missing. Furthermore,
both Beas-2B and MeT5A are SV40-immortalized cells
which may contribute to some of the gene expression
changes. However, efficient use of controls and careful
selection of bioinformatics methods should account for
these limitations and minimize the false negatives and
positives. We expect these expression profiles may provide
a better understanding of the mechanisms behind asbes-
tos-associated disease, especially when correlated with
gene expression data and CGH array data from asbestos-
exposed lung cancer and mesothelioma patients [6,8-
10,36-39].
Methods
Cell Lines
Human lung adenocarcinoma (A549) cells, human SV40-
transformed bronchial epithelial (Beas-2B) cells, and
SV40-immortalized pleural mesothelial (MeT5A) cells
(American Type Culture Collection, Rockville, MD, USA)
are well characterized and have been widely used as cell
lines in pulmonary research [21,40-42]. The cells were
cultured as described previously [43-46]. Briefly, A549
cells (American Type Culture Collection, Rockville, MD)
were cultured in nutrient mixture F-12 growth medium
supplemented with 15% fetal calf serum (FBS), 100 U/ml
penicillin and 100 mg/ml streptomycin at 37°C in a 5%
CO2 atmosphere. Beas-2B cells (National Cancer Institute,
Laboratory of Human Carcinogenesis) were cultured
according to the manufacturer' instructions (bronchial
epithelial cell growth medium [BEGM]; Clonetics Inc.,
San Diego, CA). MeT5A cells were cultured using RPMI
1640 medium supplemented with 10% heat inactivated
FBS, 0.003% L-glutamine, 100U/ml penicillin, and 100
mg/ml streptomycin at 37°C in a 5 % CO2 atmosphere.
Semi confluent cell cultures were exposed to crocidolite
(International Union Against Cancer, Johannesburg,
South Africa) (2 βg/cm2 for A549 and Beas-2B cells and 1
βg/cm2 for MeT5A cells) for different time points in the
culture medium. The fibre doses were based on previous
studies in our laboratory and by others [44-46]. Samples
were collected from each cell line before any asbestos
exposure or treatment (0h), from asbestos-exposed and
control (not exposed, parallel cultures) A549 and Beas-2B
cells at 1h, 6h, 24h, and 48h, with additional 7 days for
A549. Samples from the MeT5A cell line were collected at
1h and 48h from exposed and parallel non-exposed con-
trol cells. The cultures and exposures were conducted on
three or more separate tissue culture plates (T25 and T75),
and the cells were pooled before hybridization to elimi-
nate the need of biological replicate hybridizations. RNA
was extracted and purified using Qiagen RNeasy kit (Qia-
gen Inc., Valencia, CA, USA) and RNA quality was meas-
ured using Agilent's BioAnalyzer (Agilent Technologies,
Palo Alto, CA).
Gene Expression Microarray
All samples, including one replicate from any time point
for each cell line, were hybridized to Affymetrix Human
Genome U133 Plus 2.0 oligonucleotide microarrays
(Affymetrix, Santa Clara, CA). Reverse transcription of 5
βg high-quality total RNA to cDNA was carried out using
the Superscript Double Stranded cDNA Synthesis kit (Inv-
itrogen, Paisley, UK). The cDNA was linearly amplified
and  in vitro transcription reactions using the BioArray
high-yield RNA transcript labelling kit (T7; Enzo Life Sci-
ences, Farmingdale, NY) were carried out to produce
biotinylated CTP and UTP-labelled cRNA. Labelled and
fragmented cRNA was then hybridized to the Affymetrix
microarrays for 16 h at 45°C in a rotating oven (60 rpm).
The arrays were washed and stained with streptavidin-
phycoerythrin (SAPE) in a Fluidics station 450 [47], and
scanned with Affymetrix GeneChip Scanner 3000. The
image was analyzed using the GeneChip operating soft-
ware (GCOS; Affymetrix, Sacramento, CA) and compari-
son analysis was done according to the instructions
provided by the manufacturer.
Gene Expression Data Analysis
Affymetrix Analysis Suite v. 5 (MAS-5) was used to scale
the arrays to the target value of 100 and to define the
absent and present calls. Samples with a background of
35–70 and housekeeping control genes signal ratios close
to 1.0 were included in the data analysis.
The hybridization data was pre-processed using RMA
(Robust Multi-array Average) [48] with default settings
(i.e., quantile normalization) in R. AFFX control sets and
probe sets lacking GeneID information were excluded
from the analysis. RMA pre-processing, designed toBMC Genomics 2007, 8:62 http://www.biomedcentral.com/1471-2164/8/62
Page 12 of 14
(page number not for citation purposes)
enhance the comparability of expression values between
separate arrays, produces a single logarithmic expression
value for each probe set in the Affymetrix arrays. When
two arrays were used to measure the same experimental
conditions (replicates), the mean of the two RMA values
was used as the expression value. The technical replicates
from each cell line correlated within acceptable values.
Because Affymetrix oligonucleotide arrays are considered
reliable, we did not use additional replicates.
Gene and chromosome band assignments were obtained
from the BioConductor package 'hgu133plus2', version
1.10.0 [49]. Only unique assignments to properly named
chromosome bands were used in the analysis.
Bioinformatics Analysis
Gene Ontology Analysis
A statistical analysis of Gene Ontology (GO) annotation
terms similar to that described by Breitling et al. [50] was
performed to identify asbestos exposure-associated bio-
logical processes.
The analysis was carried out at each time point for both
under- and overexpressed groups of genes. All cell lines
were analyzed separately. Briefly, genes were first rank-
ordered according to their logarithmic fold-change values
between exposed cases and controls. When multiple
probe sets corresponded to a unique gene (GeneID), we
chose the '_at' set with the highest overall expression level
in the three cell lines. When no '_at' sets were available,
one of the sets was chosen at random. Genes involved in
each biological process were assigned and a hypergeomet-
ric distribution was used for the statistical evaluation of
enriched terms. Affected biological processes were deter-
mined by using the iGA algorithm of Breitling et al [50].
For a given gene class, iGA computes the minimal class-
wise hypergeometric "p-value". The significance of this
statistical indicator was here assessed by comparing its
value against a distribution from 10 000 random permu-
tations of the data. GO terms with permuted p-value of
less than 0.01 were considered interesting.
To detect the most detailed (with the least genes) biologi-
cal processes affected, the GO terms were ordered in
branches according to their parent-child relationships.
The branches form a tree-like structure where processes in
each branch are related. Due to this close relationship, we
assumed that truly affected processes should be detected
on several levels of the tree. We therefore identified
branches with at least three affected terms (p < 0.01).
Cluster Analysis
After RMA pre-processing and averaging of replicates, a
differential expression time series of each probe set was
formed by subtracting the expression values measured in
the non-exposed control from the values in the asbestos
exposed sample at each time point.
Probe sets were removed before cluster analysis (i) when
none of the time points showed an approximate >1.4-fold
(v2) difference between the non-exposed and exposed
cases, (ii) when the probe sets did not have an associated
gene title, and (iii) when the "present/marginal/absent"
expression rating system used in Affymetrix microarray
analysis software [47] (here, an open source implementa-
tion [51] of the Affymetrix algorithms was used instead)
declared a probe set as absent in all microarrays relevant
to the experiment. Each probe set was treated as the sole
representative of a gene. The number of probe sets
remaining after the pruning procedures was 7 538
(MeT5A), 12 436 (A549), or 16 640 (Beas-2B). A total of
19 710 out of the 54 675 different probe sets on the
Affymetrix array were included in the cluster analysis of at
least one cell line.
The reduced data set from each cell line was clustered
using an algorithm specifically designed for short time
series expression data [52,53]. Significant clusters were
not grouped as in the original paper. The clustering proce-
dure assigned each probe set into a single cluster. The total
number of clusters was set to 50, and the algorithm
labelled some as being statistically significant (p < 0.05,
Bonferroni corrected) using a permutation test.
Furthermore, the enriched biological processes (GO) as
well as enriched chromosomal regions (both referred to as
"terms" in the following) for each cluster were accounted
for by calculating the probability of having at least the
observed number of probe sets associated with a given
term, assuming a random selection of probe sets. All 54
675 probe sets on the microarray were used as a reference
set. The possible enrichment of the terms in different sub-
sets (clusters) of the reference set was evaluated by com-
puting p-values from the hypergeometric distribution.
Canonical Correlation Analysis
CCA [54] was performed on the A549 and Beas-2B cell
lines. This method describes the shared variation between
two data sets. The MeT5A cell line was omitted from the
analysis due to the scarcity of time points. Multiple probe
sets corresponding to the same gene were treated as in the
GO analysis. Genes were ordered, based on the results
from CCA, according to their contribution to the depend-
encies of the two data sets. This was measured by the
squared sum of CCA projection scores. Enrichment in 307
chromosome bands was tested. The p-values were evalu-
ated based on permutation test as in the GO analysis.BMC Genomics 2007, 8:62 http://www.biomedcentral.com/1471-2164/8/62
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